Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy
- Supplementary File 1:
DOCX-Document (DOCX, 340 KiB)
-
Externally hosted supplementary file 1
Doi: /
Link: http:///
Description: /
Devos, G.; Berghen, C.; Van Eecke, H.; Stichele, A.V.; Van Poppel, H.; Goffin, K.; Mai, C.; De Wever, L.; Albersen, M.; Everaerts, W.; De Meerleer, G.; Joniau, S. Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy. Cancers 2020, 12, 2271. https://doi.org/10.3390/cancers12082271
Devos G, Berghen C, Van Eecke H, Stichele AV, Van Poppel H, Goffin K, Mai C, De Wever L, Albersen M, Everaerts W, De Meerleer G, Joniau S. Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy. Cancers. 2020; 12(8):2271. https://doi.org/10.3390/cancers12082271
Chicago/Turabian StyleDevos, Gaëtan, Charlien Berghen, Henri Van Eecke, Arthur V. Stichele, Hendrik Van Poppel, Karolien Goffin, Cindy Mai, Liesbeth De Wever, Maarten Albersen, Wouter Everaerts, Gert De Meerleer, and Steven Joniau. 2020. "Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy" Cancers 12, no. 8: 2271. https://doi.org/10.3390/cancers12082271